Simavita Limited: Results from 2015 Annual General and Special Meeting
(firmenpresse) - SYDNEY, AUSTRALIA -- (Marketwired) -- 12/15/15 -- Simavita Limited ("Simavita" or the "Company") (ASX: SVA)(TSX VENTURE: SV) advises that the 2015 Annual General and Special Meeting of shareholders was held at 10.00 am today (Sydney time) at the offices of K&L Gates, Level 31, 1 O''Connell Street, Sydney, New South Wales, Australia.
Resolutions 1, 2, 3, 4 and 6 that were put before the shareholders were passed on a show of hands. Resolution 5, in respect of the proposed increase in the Non-Executive Director fee pool, was withdrawn prior to the meeting.
In respect of resolution 4, in which the Company sought shareholder approval under ASX Listing Rule 7.1A, the Company confirms that the resolution was passed by a sufficient majority as a special resolution (with 99.82% voting in favour), as set out on the attached page.
The proxy votes received in respect of the various resolutions are set out on the attached page.
For further information, please visit the Company''s profile on SEDAR () or the Company''s website () or contact the persons listed below.
About Simavita
Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.
About SIM™
SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.
Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit .
The TSX Venture Exchange ("TSX-V") has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither the TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this Release.
Proxy results for 2015 Annual General and Special Meeting
The Company currently has a total of 92,245,233 common shares on issue and 759 registered share/CDI holders.
(i) Excludes votes cast by Directors and parties related to them.
Contacts:
Company
Philippa Lewis
Chief Executive Officer
+61 2 8405 6381
Thomas Howitt
Chief Financial Officer
+ 61 418 351 127
Media and Investor Relations
Jane Lowe
+61 411 117 774
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.12.2015 - 12:53 Uhr
Sprache: Deutsch
News-ID 1404581
Anzahl Zeichen: 3552
contact information:
Contact person:
Town:
SYDNEY, AUSTRALIA
Phone:
Kategorie:
Alternative
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 177 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Simavita Limited: Results from 2015 Annual General and Special Meeting
"
steht unter der journalistisch-redaktionellen Verantwortung von
Simavita Limited (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
